{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:34:09Z","timestamp":1793889249905,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We report the first case of COVID-19 associated acute necrotizing encephalopathy (ANE) without pulmonary disease in a patient with an extremely high interleukin-6 (IL-6) level and Ran Binding Protein 2 (<jats:italic>RANBP2<\/jats:italic>) mutation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 29-year-old woman recently immunized with inactivated viral vaccine\u2014BBIBP32-CorV (Sinopharm) presented with alteration of consciousness. Her body temperature was 37\u00b0 Celsius, blood pressure 42\/31\u00a0mmHg, heart rate 130\u00a0bpm, respiratory rate 20 per minute, and oxygen saturation 98%. Respiratory examination was unremarkable. Neurological examination revealed stupor but preserved brainstem reflexes. Non-contrast computerized tomography of the brain showed symmetrical hypodense lesions involving bilateral thalami and cerebellar hemispheres characteristic of ANE. No pulmonary infiltration was found on chest radiograph. SARS-CoV-2 was detected by PCR; whole genome sequencing later confirmed the Delta variant. <jats:italic>RANBP2<\/jats:italic> gene analysis revealed heterozygous Thr585Met mutation. Serum IL-6 was 7390\u00a0pg\/mL. Urine examination showed pyelonephritis. Her clinical course was complicated by seizure, septic shock, acute kidney injury, and acute hepatic failure. She later developed coma and passed away in 6\u00a0days.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ANE is caused by cytokine storm leading to necrosis and hemorrhage of the brain. IL-6 was deemed as a prognostic factor and a potential treatment target of ANE in previous studies. <jats:italic>RANBP2<\/jats:italic> missense mutation strongly predisposes this condition by affecting mitochondrial function, viral entry, cytokine signaling, immune response, and blood\u2013brain barrier maintenance. Also, inactivated vaccine has been reported to precipitate massive production of cytokines by antibody dependent enhancement (ADE). The true incidence of COVID-19 associated ANE is not known as were the predictors of its development. We proposed these potential two factors (<jats:italic>RANBP2<\/jats:italic> mutation and ADE) that could participate in the pathogenesis of ANE in COVID-19 apart from SARS-CoV2 infection by itself. Further study is needed to confirm this hypothesis, specifically in the post-vaccination period. Role of <jats:italic>RANBP2<\/jats:italic> mutation and its application in COVID-19 and ANE should be further elaborated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07610-0","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T10:03:17Z","timestamp":1658570597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["COVID-19 related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement"],"prefix":"10.1186","volume":"22","author":[{"given":"Thanakit","family":"Pongpitakmetha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasin","family":"Hemachudha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7277-9699","authenticated-orcid":false,"given":"Wanakorn","family":"Rattanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poosanu","family":"Thanapornsangsuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiravat","family":"Hemachudha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"issue":"9","key":"7610_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767\u201383.","journal-title":"Lancet Neurol"},{"key":"7610_CR2","volume":"2015","author":"X Wu","year":"2015","unstructured":"Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL. Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediat Inflamm. 2015;2015: 792578.","journal-title":"Mediat Inflamm"},{"issue":"2","key":"7610_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1212\/WNL.57.2.295","volume":"57","author":"H Aiba","year":"2001","unstructured":"Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. 2001;57(2):295\u20139.","journal-title":"Neurology"},{"issue":"1","key":"7610_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-020-01896-0","volume":"17","author":"S Najjar","year":"2020","unstructured":"Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, Pacia SV, Azhar S. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflamm. 2020;17(1):231.","journal-title":"J Neuroinflamm"},{"issue":"4","key":"7610_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1941874421991370","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Younce JR, Perlmutter JS, Mar SS. Excellent outcome of acute necrotizing encephalopathy in an adult with bacterial infections, case report. Neurohospitalist. 2021;11(4):351\u20135.","journal-title":"Neurohospitalist"},{"issue":"7","key":"7610_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00247-009-1498-9","volume":"40","author":"H Aydin","year":"2010","unstructured":"Aydin H, Ozgul E, Agildere AM. Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination: diffusion-weighted imaging and proton MR spectroscopy findings. Pediatr Radiol. 2010;40(7):1281\u20134.","journal-title":"Pediatr Radiol"},{"key":"7610_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01862-4","author":"P Siriratnam","year":"2022","unstructured":"Siriratnam P, Buzzard K, Yip G. Acute haemorrhagic necrotizing encephalopathy in the setting of SARS-CoV-2 vaccination: a case report and literature review. Acta Neurol Belg. 2022. https:\/\/doi.org\/10.1007\/s13760-021-01862-4.","journal-title":"Acta Neurol Belg"},{"key":"7610_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102194","volume":"43","author":"JM Levine","year":"2020","unstructured":"Levine JM, Ahsan N, Ho E, Santoro JD. Genetic acute necrotizing encephalopathy associated with RANBP2: clinical and therapeutic implications in pediatrics. Mult Scler Relat Disord. 2020;43: 102194.","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"7610_CR9","volume":"13","author":"N Mullaguri","year":"2021","unstructured":"Mullaguri N, Sivakumar S, Battineni A, Anand S, Vanderwerf J. COVID-19 related acute hemorrhagic necrotizing encephalitis: a report of two cases and literature review. Cureus. 2021;13(4): e14236.","journal-title":"Cureus"},{"key":"7610_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4137\/CCRep.S40610","volume":"9","author":"A Mungaomklang","year":"2016","unstructured":"Mungaomklang A, Chomcheoy J, Wacharapluesadee S, Joyjinda Y, Jittmittraphap A, Rodpan A, Ghai S, Saraya A, Hemachudha T. Influenza virus-associated fatal acute necrotizing encephalopathy: role of nonpermissive viral infection? Clin Med Insights Case Rep. 2016;9:99\u2013102.","journal-title":"Clin Med Insights Case Rep"},{"key":"7610_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102506","volume":"114","author":"Y Rodriguez","year":"2020","unstructured":"Rodriguez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, Ramirez-Santana C, Costanzo A, Ridgway WM, Ansari AA, et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun. 2020;114: 102506.","journal-title":"J Autoimmun"},{"issue":"6","key":"7610_CR12","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00134-020-06028-z","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(6):1294\u20137.","journal-title":"Intensive Care Med"},{"issue":"1","key":"7610_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12879-021-05945-8","volume":"21","author":"P Sabaka","year":"2021","unstructured":"Sabaka P, Koscalova A, Straka I, Hodosy J, Liptak R, Kmotorkova B, Kachlikova M, Kusnirova A. Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak. BMC Infect Dis. 2021;21(1):308.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"7610_CR14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","volume":"222","author":"Y Chi","year":"2020","unstructured":"Chi Y, Ge Y, Wu B, Zhang W, Wu T, Wen T, Liu J, Guo X, Huang C, Jiao Y, et al. Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China. J Infect Dis. 2020;222(5):746\u201354.","journal-title":"J Infect Dis"},{"issue":"6","key":"7610_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41577-021-00553-8","volume":"21","author":"SA Jones","year":"2021","unstructured":"Jones SA, Hunter CA. Is IL-6 a key cytokine target for therapy in COVID-19? Nat Rev Immunol. 2021;21(6):337\u20139.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"7610_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12967-020-02571-x","volume":"18","author":"J Zhang","year":"2020","unstructured":"Zhang J, Hao Y, Ou W, Ming F, Liang G, Qian Y, Cai Q, Dong S, Hu S, Wang W, et al. Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study. J Transl Med. 2020;18(1):406.","journal-title":"J Transl Med"},{"issue":"1","key":"7610_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00221-021-06244-z","volume":"240","author":"S Veleri","year":"2022","unstructured":"Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res. 2022;240(1):9\u201325.","journal-title":"Exp Brain Res"},{"issue":"8","key":"7610_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","volume":"21","author":"M Sadarangani","year":"2021","unstructured":"Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol. 2021;21(8):475\u201384.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"7610_CR19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","volume":"5","author":"WS Lee","year":"2020","unstructured":"Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020;5(10):1185\u201391.","journal-title":"Nat Microbiol"},{"issue":"1","key":"7610_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s42003-022-03207-0","volume":"5","author":"S Wang","year":"2022","unstructured":"Wang S, Wang J, Yu X, Jiang W, Chen S, Wang R, Wang M, Jiao S, Yang Y, Wang W, et al. Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcgammaRIIB and virus-antibody complex with bivalent interaction. Commun Biol. 2022;5(1):262.","journal-title":"Commun Biol"},{"issue":"6","key":"7610_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1084\/jem.20020781","volume":"196","author":"FP Polack","year":"2002","unstructured":"Polack FP, Teng MN, Collins PL, Prince GA, Exner M, Regele H, Lirman DD, Rabold R, Hoffman SJ, Karp CL, et al. A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med. 2002;196(6):859\u201365.","journal-title":"J Exp Med"},{"issue":"9427","key":"7610_CR22","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/S0140-6736(04)16501-X","volume":"363","author":"A Bukreyev","year":"2004","unstructured":"Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, Murphy BR, Subbarao K, Collins PL. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet. 2004;363(9427):2122\u20137.","journal-title":"Lancet"},{"issue":"22","key":"7610_CR23","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1016\/j.vaccine.2021.01.055","volume":"39","author":"FM Munoz","year":"2021","unstructured":"Munoz FM, Cramer JP, Dekker CL, Dudley MZ, Graham BS, Gurwith M, Law B, Perlman S, Polack FP, Spergel JM, et al. Vaccine-associated enhanced disease: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39(22):3053\u201366.","journal-title":"Vaccine"},{"issue":"1","key":"7610_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","volume":"21","author":"S Xia","year":"2021","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial. Lancet Infect Dis. 2021;21(1):39\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"7610_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/jnnp.58.5.555","volume":"58","author":"M Mizuguchi","year":"1995","unstructured":"Mizuguchi M, Abe J, Mikkaichi K, Noma S, Yoshida K, Yamanaka T, Kamoshita S. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry. 1995;58(5):555\u201361.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"7610_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ajhg.2008.12.009","volume":"84","author":"DE Neilson","year":"2009","unstructured":"Neilson DE, Adams MD, Orr CM, Schelling DK, Eiben RM, Kerr DS, Anderson J, Bassuk AG, Bye AM, Childs AM, et al. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009;84(1):44\u201351.","journal-title":"Am J Hum Genet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07610-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07610-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07610-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T10:04:24Z","timestamp":1658570664000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07610-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7610"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07610-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"8 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Institutional Review Board, Faculty of Medicine, Chulalongkorn University (COE No. 020\/2022. IRB No. 0274\/65).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin. The patient\u2019s next of kin provided written informed consent for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no relevant disclosures or conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"640"}}